Thermo Fisher Scientific Inc. (TMO)
| Market Cap | 183.06B |
| Revenue (ttm) | 43.21B |
| Net Income (ttm) | 6.58B |
| Shares Out | 377.61M |
| EPS (ttm) | 17.30 |
| PE Ratio | 28.03 |
| Forward PE | 20.67 |
| Dividend | $1.72 (0.35%) |
| Ex-Dividend Date | Sep 15, 2025 |
| Volume | 2,054,643 |
| Open | 480.44 |
| Previous Close | 477.41 |
| Day's Range | 478.72 - 486.98 |
| 52-Week Range | 385.46 - 627.88 |
| Beta | 0.75 |
| Analysts | Buy |
| Price Target | 583.25 (+20.31%) |
| Earnings Date | Jul 23, 2025 |
About TMO
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for phar... [Read more]
Financial Performance
In 2024, Thermo Fisher's revenue was $42.88 billion, an increase of 0.05% compared to the previous year's $42.86 billion. Earnings were $6.34 billion, an increase of 5.67%.
Financial StatementsAnalyst Forecast
According to 16 analysts, the average rating for TMO stock is "Buy." The 12-month stock price target is $583.25, which is an increase of 20.31% from the latest price.
News
Final Trades: Toast, Transdigm, Thermo Fisher and Amazon
The Investment Committee give you their top stocks to watch for the second half.
Thermo Fisher: Growth Acceleration And Margin Expansion Should Drive The Upside
Revenue growth is accelerating, led by pharma/biotech momentum and bioproduction demand. The medium-term margin outlook is positive with cost cuts, AI-driven efficiencies, and lapping of tariff headwi...
Thermo Fisher Receives FDA Approval for NGS-Based Companion Diagnostic for New Non-Small Cell Lung Cancer Treatment
CARLSBAD, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, has received approval from the U.S. Food and Drug Administration (FDA) for its Oncomine Dx Target Test...
Thermo Fisher: The Rerating Is Just Getting Started - Buy
Thermo Fisher is emerging from a challenging period with solid fundamentals, strong cash flow, and renewed growth, making it undervalued by the market. Recent earnings showed organic growth, margin ex...
Baron Capital's Top Health Care Stock Picks And Misses From Q2 2025
We added key positions in Masimo, Exact Sciences, Eli Lilly, Penumbra, and Edwards Lifesciences, each with strong growth drivers and market leadership. Our investment in Masimo is supported by divesti...
Baron Health Care Fund Q2: Top Contributors, Misses, And Strategic Shifts
Insmed, Intuitive Surgical, and IDEXX Laboratories were top contributors, driven by strong drug pipelines, innovation, and robust financial results. We exited UnitedHealth Group due to earnings misses...
Thermo Fisher Q2: Pharma And Biotech Gains Offset By Weak Academic And Gov't Markets
I reiterate my Buy rating on Thermo Fisher Scientific Inc., with a fair value estimate of $568 per share, reflecting its undervalued stock price. Q2 FY25 results showed early signs of market recovery,...
Trade tracker: Bill Baruch buys Thermo Fisher
Bill Baruch, founder and president at Blue Line Capital, joins CNBC's “Halftime Report” to explain why he's buying Thermo Fisher here.
Thermo Fisher Scientific Showcases Diagnostics Solutions Designed to Meet Evolving Global Healthcare Demands at ADLM 2025
CHICAGO--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, showcases its innovations in improving clinical and diagnostic laboratory efficiency and workflow optimization ...
Thermo Fisher Scientific Increases Accessibility to Research With the Launches of Scios 3 and Talos 12 Electron Microscopes at M&M 2025 Conference
WALTHAM, Mass.--(BUSINESS WIRE)--As the world leader in serving science, Thermo Fisher Scientific is proud to announce the launch of two new electron microscopes that will be unveiled at Microscopy & ...
Why Thermo Fisher Stock Is Rising Wednesday
Thermo Fisher Scientific Inc. TMO on Wednesday reported second-quarter 2025 adjusted earnings of $5.36 per share, beating the street view of $5.23.
Thermo Fisher Scientific Stock Jumps on Strong Results, Higher Outlook
Thermo Fisher Scientific (TMO) shares took off after the maker of lab equipment and other life sciences products posted better-than-expected results and boosted its guidance, citing operational improv...
Thermo Fisher Scientific Inc. (TMO) Q2 2025 Earnings Call Transcript
Thermo Fisher Scientific Inc. (NYSE:TMO) Q2 2025 Earnings Conference Call July 23, 2025 8:30 AM ET Company Participants Marc N. Casper - Chairman, President & CEO Rafael Tejada - Vice President of In...
Thermo Fisher Scientific's Chief Financial Officer, Stephen Williamson, to Retire in Early 2026
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that Stephen Williamson, senior vice president and chief financial offi...
Thermo Fisher beats quarterly estimates on resilient demand for its tools and services
Thermo Fisher on Wednesday beat Wall Street estimates for second-quarter profit and revenue, helped by steady demand for its products and services used for developing therapies.
Thermo Fisher Scientific Reports Second Quarter 2025 Results
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the second quarter ended June 28, 2025. Second...
Thermo Fisher Scientific Company Analysis Report | Key Milestones/History, Product Offerings, Technologies, Major Applications and End-user Industries
Discover an in-depth analysis of Thermo Fisher Scientific in this comprehensive report, covering milestones, product offerings, and technologies. Explore their financial performance, strategic allianc...
Thermo Fisher acquires Sanofi's New Jersey manufacturing site
Thermo Fisher said on Wednesday it will buy Sanofi's manufacturing site in Ridgefield, New Jersey, to produce critical medicines for the French drugmaker.
Thermo Fisher Scientific and Sanofi Expand Strategic Partnership to Enable Additional U.S. Drug Product Manufacturing
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced an expansion of their strategic partnership with Sanofi to enable additi...
Thermo Fisher Scientific Introduces the Oncomine Comprehensive Assay Plus on the Ion Torrent Genexus System to Help Advance the Future of Precision Medicine
CARLSBAD, Calif.--(BUSINESS WIRE)--Today, Thermo Fisher Scientific announced that the Oncomine™ Comprehensive Assay Plus* is now available on the Ion Torrent™ Genexus™ System* helping accelerate preci...
Thermo Fisher Scientific Declares Quarterly Dividend
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0....
Nalgene Outdoor Launches Wild Expressions Collaboration with AtomicChild to Inspire Mindfulness Just in Time for Summer Adventures and Back-to-School
ROCHESTER, N.Y.--(BUSINESS WIRE)--Today, Nalgene Outdoor unveils its new limited-edition “Wild Expressions” series on 16 oz narrow-mouth bottles, its second partnership with Colorado artist Jimmy Brya...
Thermo Fisher Scientific: Recovery In Sight, Attractively Valued
Thermo Fisher has good growth prospects ahead. Core pharma, biotech, and bioproduction businesses are driving growth, with US manufacturing investments and the Solventum acquisition strengthening futu...
4 Of The Hottest Great American SWANs For The 4th Of July
I highlight four American SWAN stocks - Realty Income, Alphabet, Globe Life, and Thermo Fisher Scientific - offering stress-free, blue-chip investment opportunities. Each company boasts strong managem...
Thermo Fisher's NGS Assay Receives FDA Approval as a Companion Diagnostic for ZEGFROVY and for Tumor Profiling
CARLSBAD, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced the U.S. Food and Drug Administration (FDA) has approved the Oncomine™ Dx Express Test...